Notable Mergers and Acquisitions of the Day: MOT, BDX

November 20, 2009 10:05 AM EST

• Motorola, Inc. (NYSE: MOT) today announced the acquisition of RadioFrame Networks' iDEN business. RadioFrame is a provider of lower cost, power efficient iDEN technology. Terms of the transaction were not disclosed. RadioFrame Networks' iDEN business will be integrated into Motorola's Home & Networks Mobility business.
  
  Motorola's proprietary iDEN solution has proven to be an enduring cellular technology due to its innovative and differentiated end-user fast dispatch service and enterprise optimized talk-groups. RadioFrame's iDEN products will further enhance Motorola's portfolio for multi-channel base stations optimized to support non-contiguous spectrum allocations in the special mobile radio (SMR) business that are especially common outside North America.
  
  For Motorola's iDEN customers, RadioFrame's base stations can flexibly manage non-contiguous spectrum channels, and its technology offers a lower cost architecture with a highly efficient use of power amplifiers, a smaller physical footprint and more flexibility in site management. RadioFrame's iDEN technology also offers lower power consumption, lowering operating expenses.
  
  With this acquisition, Motorola can further enhance its push-to-talk technology roadmap plans for strengthened operational capability, end-user functionality and cost-effective expansion.
  
  
• BD (NYSE: BDX) today announced the completion of its acquisition of HandyLab, Inc., an Ann Arbor, Michigan-based company that develops and manufactu♦res molecular diagnostic assays and automation platforms.
  
  In May 2009, BD and HandyLab announced an exclusive agreement for BD to develop and commercialize molecular assays on the HandyLab Jaguar platform, the first fully integrated molecular diagnostic system to provide hands-off operation, incorporating clinical sample preparation, nucleic acid extraction, and microfluidic real-time polymerase chain reaction (PCR) amplification and detection in a simple bench-top system. The self-contained workstation is designed to accommodate both batch workflows and on-demand testing for maximum lab efficiency and flexibility.
  
  With this acquisition, BD will migrate its BD GeneOhm molecular assays for Methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile and Vancomycin-resistant Enterococcus (VRE) onto the new platform and will market them as the new BD MAX system, an evolution of the current Jaguar(TM) system.
  
  
  
  
• 
  
  
  
  

To see all the Mergers & Acquisitions for today in real-time go to http://www.streetinsider.com/Mergers+and+Acquisitions

Related Categories

Special Reports

Stocks Mentioned

Related Entities

• Notable Mergers and Acquisitions

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?